Source: c19study.com

The studies continue to roll out, and there has been very positive results in pre and post exposure as well as early treatment of confirmed COVID-19 patients ( near 100%). There is also considerable efficacy (62%) when treating late. Most studies concur.

Check out c19study.com for the up to date tally on what is evolving. The site is live and constantly updated.
blank

Check out c19study.com for the up to date tally on what is evolving. The site is live and constantly updated.




See Related:
Hydroxychloroquine significantly lowers COVID-19 death rate, Henry Ford Health study finds

NY Study: Risk Factors for Mortality in Patients with COVID-19 in New York City

Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.

Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as an ambulatory treatment for COVID-19 patients in Cameroon.

Global Research: Media Sabotage of Hydroxychloroquine Use for COVID-19; Doctors Worldwide Protest the Disaster

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Professor Borody Talks about Early Treatment of COVID-19 – Part 1 – September 2020

We treat them for 10 days using an appropriate dose of ivermectin, doxycycline daily and zinc daily.

They all actually have activity against the intracellular multiplication of the virus and from published data you can read that most of the results have been close to 100 percent cure there was one that used the lower level and got 92 percent cure but it’s just hard to believe how simple it is to cure coronavirus.

Read More »